We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Product Safety Report for fashion watch and jewellery set presenting a serious risk to health.
First published during the 2022 to 2024 Sunak Conservative government
First published during the 2019 to 2022 Johnson Conservative government
New measures strengthen the safe use of the acne drug isotretinoin for patients across the UK, following a patient-focused expert review
Information on ethylene glycol (also known as 1,2-ethanediol, ethane-1,2-diol, or mono ethyl glycol) for use in responding to chemical incidents.
Employment Tribunal decision.
No action is currently needed from patients. No one should stop taking valproate without advice from their healthcare professional.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).